Search Results - "LILLIBRIDGE, James H"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin by HSYU, Poe-Hirr, SCHULTZ-SMITH, Melissa D, LILLIBRIDGE, James H, LEWIS, Ronald H, KERR, Bradley M

    Published in Antimicrobial Agents and Chemotherapy (01-12-2001)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate by LILLIBRIDGE, J. H, BAI HONG LIANG, KERR, B. M, WEBBER, S, QUART, B, SHETTY, B. V, LEE, C. A

    Published in Drug metabolism and disposition (01-07-1998)
    “…In vitro studies with human liver microsomes and P450 probe substrates were performed to characterize selectivity and mechanism of cytochrome P450 inhibition…”
    Get full text
    Journal Article
  3. 3

    Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1 by Kharasch, E D, Thummel, K E, Mhyre, J, Lillibridge, J H

    Published in Clinical pharmacology and therapeutics (01-06-1993)
    “…Disulfiram and its reduced metabolite diethyldithiocarbamate have been identified previously as selective mechanism-based inhibitors of human liver microsomal…”
    Get more information
    Journal Article
  4. 4

    Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation by Lee, C A, Lillibridge, J H, Nelson, S D, Slattery, J T

    “…Metabolism of acetaminophen (APAP) to its reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI) is mediated by cytochrome P450. A pharmacokinetic study was…”
    Get more information
    Journal Article